Cargando…
What can we learn from drug marketing efficiency?
The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group Ltd.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230247/ https://www.ncbi.nlm.nih.gov/pubmed/19050331 http://dx.doi.org/10.1136/bmj.a2591 |